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Background: Highly pathogenic influenza viruses cause high levels of morbidity, including excessive infiltration of
leukocytes into the lungs, high viral loads and a cytokine storm. However, the details of how these pathological
features unfold in severe influenza infections remain unclear. Accumulation of Gr1 + CD11b +myeloid cells has
been observed in highly pathogenic influenza infections but it is not clear how and why they accumulate in the
severely inflamed lung. In this study, we selected this cell population as a target to investigate the extreme
inflammatory response during severe influenza infection.
Results: We established H1N1 IAV-infected mouse models using three viruses of varying pathogenicity and noted
the accumulation of a defined Gr1 + CD11b +myeloid population correlating with the pathogenicity. Herein, we
reported that CCR2+ inflammatory monocytes are the major cell compartments in this population. Of note, impaired
clearance of the high pathogenicity virus prolonged IFN expression, leading to CCR2+ inflammatory monocytes
amplifying their own recruitment via an interferon-α/β receptor 1 (IFNAR1)-triggered chemokine loop. Blockage
of IFNAR1-triggered signaling or inhibition of viral replication by Oseltamivir significantly suppresses the expression
of CCR2 ligands and reduced the influx of CCR2+ inflammatory monocytes. Furthermore, trafficking of CCR2+
inflammatory monocytes from the bone marrow to the lung was evidenced by a CCR2-dependent chemotaxis.
Importantly, leukocyte infiltration, cytokine storm and expression of iNOS were significantly reduced in CCR2−/−
mice lacking infiltrating CCR2+ inflammatory monocytes, enhancing the survival of the infected mice.
Conclusions: Our results indicated that uncontrolled viral replication leads to excessive production of inflammatory
innate immune responses by accumulating CCR2+ inflammatory monocytes, which contribute to the fatal outcomes
of high pathogenicity virus infections.
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Influenza A virus (IAV) is a common human respiratory
virus and causes seasonal epidemic and pandemic infec-
tions. In the past 100 years, pandemics of influenza have
been caused by the IAV strains H1N1 (1918), H2N2
(1957), H3N2 (1968) and H1N1 (2009) [1,2]. These pan-
demic strains vary in their virulence and pathogenicy.
Compared to the 1968 and 2009 pandemics, the 1957
pandemic featured intermediate pathogenicity, while the
virus causing the 1918 pandemic was relatively highly
pathogenic in the human population [2]. Currently we
are threatened by sporadic infections by emerging avian
IAVs, including highly pathogenic avian H5N1 and H7N9
viruses [1,3]. Two well known, highly pathogenic IAVs,
1918 H1N1 and avian H5N1 cause high levels of mor-
bidity including excessive infiltration of neutrophils and
monocytes into the lungs, high viral loads and hypercyto-
kinemia, with significant increases of IL-1, IL-6, IL-8,
TNF, CXCL10 and CCL2 in the patients’ plasma [4-6].
Thus, cytokines and chemokines induced at high levels by
IAV infections have become targets for the development
of IAV therapy. However, the results of experiments using
knock-out mice indicate that none of them alone deter-
mines highly pathogenic virus-induced lethality [7,8].
Thus, we used another approach to identify the im-
mune cell types that are recruited during infection and
contribute to the excessive inflammatory responses during
highly pathogenic virus infection.
H1N1 IAV circulate continuously in the human popu-
lation, and the three H1N1 strains selected for this study
display low, intermediate and high virulence in mice as
follows: (1) seasonal H1N1 A/Taiwan/141/02 (141; low
virulence); (2) pandemic H1N1 A/Taiwan/126/2009 (swine-
origin influenza virus, SOIV; intermediate virulence) and
(3) mouse adapted H1N1 A/Puerto Rico/8/34 (PR8; high
virulence). Using these mouse models, we demonstrated
that rate of viral clearance and disease severity is corre-
lated with the numbers of a defined Gr1 + CD11b +
myeloid population in the lung. Until now, it is not clear
how and why they accumulate in the severely inflamed
lung. In this study, we selected this cell population as a
target to investigate the extreme inflammatory response
during severe IAV infection.
In this paper, we report that CCR2+ inflammatory mono-
cytes are the major cell components in this defined Gr1 +
CD11b +myeloid population. Multiple roles of CCR2+ in-
flammatory monocytes during viral infections have been re-
ported: promoting host survival of West Nile virus-induced
encephalitis and IAV and mouse hepatitis virus infections
[9-12], stimulating anti-viral Th1 immunity in HSV-2
infection [13] and suppressing anti-viral CD8 T cell re-
sponses in mouse cytomegalovirus (MCMV) and persist-
ent lymphocytic choriomeningitis virus (LCMV) infections
[14,15]. These results indicate that CCR2+ inflammatorymonocytes play a double edge sword in anti-viral re-
sponses and immunopathogenesis. Using established
infection models with variable rates of viral clearance,
which are accompanied by different levels of inflamma-
tory infiltrates, we found that an amplified inflammatory
chemokine feedback loop links the impaired clearance of
highly pathogenic virus and a massive infiltration of CCR2+
inflammatory monocytes. So, we sought to investigate
which cell types are responsible for the production of
CCR2 ligands. Furthermore, we identified the inflamma-
tory signals that are triggered by an impaired anti-viral
response to induce expression of CCR2 ligands. Finally,
the pathological effects of excessive accumulated CCR2+
inflammatory monocytes were explored during highly
pathogenic IAV infection.
Overall, we provided a comprehensive study to address
the detail mechanism why and how accumulated CCR2+
inflammatory monocytes involved in highly pathogenic
IAV infections. Impaired clearance of virus led to spread
of virus to newly arrived CCR2+ inflammatory mono-
cytes and to sustain production of IFNAR1-induced CCR2
ligands, which attract BM-derived CCR2+ monocytes mi-
grated to inflamed lung and amplify their own recruitment
continuously through the IFNAR1-dependent chemokine
feedback loop, resulting in an enhancement of CCR2+ in-
flammatory monocytes-mediated pathological effects.
Methods
Mouse strains
C57BL/6 and CCR2−/− mice were purchased from Jackson
Laboratory (Bar Harbor, ME, USA). IFNAR1−/− mice
were obtained from Dr. Chien-Kuo Lee (Graduate Institute
of Immunology, National Taiwan University, Taipei, Taiwan).
MyD88−/− mice were obtained from Hui-Chen Chen
(Graduate Institute of Basic Medical Science, China
Medical University, Taichung, Taiwan). Mice were main-
tained under specific pathogen free conditions in Chang
Gung University. All animal experiments were performed
according to the animal protocol approved by the Institu-
tional Animal Care and User Committee of Chang Gung
University and in accordance with the guidelines of Animal
Care and Use of Laboratory Animals of the Taiwanese
Council of Agriculture.
Virus preparation and inoculation
All segmented expression plasmids of IAV were kindly
provided by Dr. Shin-Ru Shih of Research Center for
Emerging Viral Infections, College of Medicine, Chang
Gung University, Taiwan. Recombinant IAVs, seasonal
141, pandemic SOIV and mouse adapted PR8 were gener-
ated using a reverse genetics system, according to previous
reports [16,17]. Briefly, 293 T cells were transfected by
using 15 μl Trans IT-LT1 (Mirus Bio LLC) with 1 μg per
each plasmid (pPolI-PB2, −PB1, −PA, −HA, −NP, −NA,
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harvested and propagated in 10 day-old embryonated
chicken eggs. Harvested viruses were aliquoted and stored
at −80°C until use. For IAV inoculation, mouse was in-
fected intranasally with 200 PFU of virus.
Plaque assays
Lungs were harvested and grind tissue suspension were
frozen in 600 μl aliquots. Viral supernatant was thawed
and then 10 folds serially diluted. MDCK cells were cul-
tured at a density of 1 × 106 cells/well in a 6 well-plate.
One hundred microliter of each serial dilution contain-
ing trypsin was added to 90% confluent of MDCK cells.
After 1 hour incubation, each well was overlaid with a
ratio of 1:1 mixture of 0.8% agarose and 2× serum free
DMEM to wells. Two days later, the plaques were visual-
ized by addition of 1% crystal violet and plaque forming
unit (units/lung) was calculated.
Preparation of lung leucocytes, mediastinal lymph node
(MLN), bone marrow (BM) cells and PBMC
Harvested lungs were homogenized using a metal mesh
and the suspension was treated with type I collagenase
(Invitrogen) per lung for 30 mins at 37°C. Cells were re-
covered and washed once with complete PRMI medium
containing 10% FBS, 1 mM glutamine, 100 U/ml of
penicillin and 100 μg/ml of streptomycin. The pelvic and
femoral bones were harvested and BM cells were flushed
out with complete RPMI medium by insertion of a 1 ml
syringe with a 25G needle into one end of the bone.
MLN cells were homogenized using glass slides with
ground edges. Leukocytes were obtained from the lungs,
peripheral blood, BM and MLN after RBC lysis buffer
treatment.
Cytokine antibody array and ELISA
To obtain bronchoalveolar lavage fluid (BALF), airways
were flushed three times with 0.5 ml sterile PBS and
centrifuged to remove infiltrating cells. Pooled BALFs
were assayed using the R & D mouse cytokine arrays
(R & D Systems, Inc.) according to the manufacturer’s
instructions. CCL2, CCL7 and CCL12 proteins were mea-
sured in serum using ELISA kits (eBioscience) according
to the manufacturer’s instructions.
Immunofluorescent surface and intracellular staining
Two million cells were stained with fluorescently labeled
mAbs, including Gr1, CD11b, Ly6C, Ly6G, CCR2 and
CX3CR1 for 30 min at 4°C. All Abs were purchased from
BD Biosciences, except for CCR2 mAb (R & D Systems).
After staining, the cells were fixed with Cytofix (BD
Biosciences) for 5 min at 4°C. For intracellular staining, cells
were stained with fluorescently labeled anti-Gr1, −CD11b
and -Ly6C mAbs and then fixed with Cytofix/cytoperm(BD Biosciences) for 20 mins at 4°C. Fixed cells were fur-
ther stained with FITC-labeled anti-IAV nucleoprotein
(NP) Ab (Abcam) for another 30 min at 4°C. Finally, the
cells were washed and re-suspended in FACS buffer (PBS
with 2% FBS) and analyzed by LSRII flow cytometry (BD
Biosciences).
Cell sorting and Wright stain
Infiltrating leukocytes from the lungs were harvested and
incubated with anti-Gr1, −CD11b and -Ly6G mAbs.
Gr1 + CD11b+, Gr1-CD11b-, Gr1 + CD11b + Ly6G+ (for
granulocyte sorting) or Gr1 + CD11b + Ly6G- (for mo-
nocyte sorting) leukocytes were sorted by FACS Aria
(BD Biosciences). For morphological evaluation of Gr1 +
CD11b + cells, sorted cells were spun onto glass slides at
250 rpm for 5 min using a Shandon Cytospin 3 Centrifuge
(Global Medical Instrumentation Inc.) and stained with
HemaTek stain Pak (Siemens Healthcare Diagnostic Inc.)
using an automatic HemaTek hematology stainer (Bayer
Healthcare, LLC.).
RNA extraction, reverse transcription and quantitative
polymerase chain reaction (RT-QPCR)
Total RNA was extracted from isolated or sorted cells using
TRIzol reagent (Invitrogen) according to the manufactu-
rer’s instructions. RNA was used to synthesize cDNA with
Superscript III reverese transcriptase (Invitrogen). TaqMan®
Gene Expression Assays (Applied Biosystems) were perfor-
med to detect mouse CCL2, CCL7, CCL12, iNOS, IFNβ
and GADPH mRNAs. Expression of the various genes was
normalized with the GADPH level in each group. Relative
gene expression was determined using △△Ct analysis.
Western blotting
Frozen lung tissues were lysed using lysis buffer (100 mM
Tris, 250 mM NaCl, 0.5% sodium deoxycholate, 1 mM
PMSF and 0.5% NP40). Tissue lysates were resolved by elec-
trophoresis in SDS-polyacrylamide gels and electrotrans-
ferred onto Hybond-P PVDF membranes (GE Healthcare).
Milk blocked blots were incubated with anti-actin and -NP
antibodies at 4°C overnight and then washed and incubated
with horseradish peroxidase (HRP)-conjugated secondary
antibodies (Jackson ImmunoResearch) at room temperature
for 1 hr. The proteins were revealed using the Immobilon
Western Chemiluminescent HRP Substrate (Millipore).
Oseltamivir treatment
PR8-infected mouse was treated with 50 mg Oseltamivir
daily according to a previous report [18].
Treatment with anti-IFNAR1 blocking antibody
Day 3 post-infected mice were anesthetized and then
injected intranasally with either 50 μg of IgG isotype
control antibody (Abcam) or 50 μg of anti-IFNAR1
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Figure 1 (See legend on next page.)
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Figure 1 Excessive accumulation of CCR2+ inflammatory monocytes in severe IAV infection. C57BL/6 mice were infected with 200 PFU of
141, SOIV or PR8 viruses. (A) Body weights were monitored daily until day 14 post-infection (n = 6 -8 per group, mean ± SEM). (B) Appearance of
lung inflammation was photographed at days 3 and 7 post-infection (n = 3 per group). (C) Total leukocytes were stained with Abs against Gr1
and CD11b. The percentage of Gr1 + CD11b +myeloid cells was analyzed by flow cytometry. (D) Total leukocytes were harvested from the lungs
at the time points indicated and counted by trypan blue exclusion. These data are a composite of four to seven independent experiments (n = 3
per group, mean ± SEM; n.s: no significant difference; *P < 0.05; **P < 0.01). (E) Numbers of Gr1 + CD11b +myeloid cell of lung were shown. These
data are a composite of four independent experiments (n = 3 per group, mean ± SEM; ns: no significant difference; *P < 0.05; ** P < 0.01). (F, upper panel)
Gr1 + CD11b + cells were sorted from infiltrating leukocytes and then stained by Wright stain. The cell morphology was photographed under 1000×
magnification using an Olympus microscope. Granulocytes are indicated by arrow heads and monocytes are indicated by arrows. (F, lower panel). The
percentage of Ly6G-Ly6Chigh monocytes in the Gr1 + CD11b + gated population is shown. Dot plots are the representative result from three repeated
experiments with three mice per group. (G) The percentage of CCR2+ inflammatory monocytes and CX3CR1 patrolling monocytes in Gr1 + CD11b +
myeloid cells. (H) Numbers of Ly6ChighCCR2+ inflammatory monocytes were shown at day 7 post-infection. This is a representative result from four
repeated experiments with three mice per group.
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counted and then stained with specific Abs against with
Gr1, CD11b, Ly6G, Ly6C and CCR2.
Adoptive transfer of BM enriched CCR2+ monocytes into
mice
BM cells from naïve B6 mice were harvested and mono-
cytes were enriched by negative selection using an EasySep™
Mouse Monocyte Enrichment Kit and EasySep™ magnet
system (STEMCELL Technologies Inc.). Enriched mono-
cytes were suspended in PBS at a concentration of 2.0 ×
107 cells/ml and incubated with 5 μM carboxyfluorescein
diacetate succinimidyl ester (CFSE, Invitrogen) solution
for 12 min at 37°C. One million CFSE-labeled cells were
adoptively transferred via the tail vein into naïve or virus-
infected mice. After 2 days, leukocytes were harvested
from the lungs and stained with anti-Ly6C and anti-CCR2
antibodies. Finally, CCR2 +CFSE + transferred monocytes
were traced using flow cytometric analysis.
Statistical analysis
Statistical significance of the data was analyzed by Student’s
two-tailed t test.
Results
Excessive accumulation of CCR2+ inflammatory monocytes
in severe IAV infection
We observed varying levels of body weight change and
lung inflammation in the infected mice and investigated
which infiltrating cell type was associated with severe in-
flammation. As shown in Figure 1A, mice infected with
the mild 141 strain lost 5%-10% of their original body
weight, while the moderate SOIV strain caused 15%-20%
original body weight loss. Notably, severe PR8 infection
caused progressive weight loss and led to 100% mortality
in the infected mice at day 7–10 post-infection. In
these infections, lung inflammation was dramatically
correlated with body weight loss at day 7 post-infection
(Figure 1B). Furthermore, we demonstrated that a definedGr1 + CD11b + myeloid population is preferentially re-
cruited to the infected lung, but only few to MLN
(Figure 1C). Of interest, the total numbers of infiltrating
leukocytes and Gr1 + CD11b + cells were significantly as-
sociated with the severity of inflammation (Figure 1D and
E). Gr1 + CD11b + cells are a heterogeneous cell popula-
tion, so the true identity of major infiltrating cells should
be further characterized using the Wright stain and by
the expression of Ly6G and Ly6C on cell surface. Gr1 +
CD11b + sorted cells consisted mostly of mononuclear
cells containing abundant cytoplasmic vacuoles and few
segmented granulocytes (Figure 1F, upper panel). Further-
more, Gr1 + CD11b + cells are composed of appoximately
68-81% monocytes (Ly6G-Ly6Chigh) and 19-32% granulo-
cytes (Ly6G + Ly6Cintermediate) (Figure 1F, lower panel).
Using specific Abs against surface CCR2 and CX3CR1,
we further demonstrated that the infiltrating monocytes
in the lungs were Ly6ChighCCR2+ inflammatory mono-
cytes but not Ly6ClowCX3CR1+ patrolling monocytes
(Figure 1G). Importantly, the numbers of infiltrating
CCR2+ inflammatory monocytes were highly associated
with the severity of inflammation (Figure 1H).
Cytokine and chemokine profiling of BALFs
To investigate the mechanism of extensive accumulation
of CCR2+ inflammatory monocytes in severe inflamma-
tion, the cytokines and chemokines listed in Figure 2A
were evaluated. According to the results of protein arrays,
levels of G-CSF, CCL1, CCL2, CCL12, IL-10, CXCL9, IL-
16 and CCL5 were correlated with the severity of lung in-
flammation (Figure 2A). Notably, both CCL2 and CCL12
are ligands of CCR2, in addition to CCL7. So, we specu-
lated that the aggressive recruitment of CCR2+ inflamma-
tory monocytes is linked to expression of CCR2 ligands.
In Figure 1C, we found that Gr1 + CD11b + cells preferen-
tially migrate to the lung but not to MLN. Therefore, we
suggested that leukocytes infiltrating the lung may fre-
quently induce CCR2 ligands to attract CCR2+ inflamma-
tory monocytes. Indeed, all transcripts of CCR2 ligands
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Figure 2 Expression of CCR2 ligands in BALF, MLN, lung and serum of infected mice. C57BL/6 mice were infected with 200 PFU of 141,
SOIV or PR8 viruses. BALF was harvested from naïve or virus-infected mice at days 3 and 7 post-infection (n = 3–4 mice per group). (A) Pooled
BALFs were subjected to cytokine or ckemokine expression analysis using cytokine protein arrays. (B) Mice were infected with PR8 viruses. At day
7 postinfection, RNAs were harvested from isolated MLN and lung leukocytes. Relative expression of CCL2, CCL7 and CCL12 in total leukocytes
from MLN and lung was measured by RT-QPCR. The mRNA relative folds were determined by normalizing the level of each group to the corresponding
GAPDH level and then to total leukocytes from MLN (mean ± SEM). Experiment (n = 3 mice per group) was performed twice and one representative
is shown. (C) Sera were collected from naïve and virus-infected mice at days 3 and 7 post-infection. Concentrations of CCL2, CCL7 and CCL12
in the sera were measured by ELISA (n = 6–11 mice per group, mean ± SEM; ns: no significant difference; *P < 0.05; **P < 0.01; ***P < 0.001).
Lin et al. Journal of Biomedical Science 2014, 21:99 Page 7 of 18
http://www.jbiomedsci.com/content/21/1/99were over 4000 fold higher in the lung than in MLN
(Figure 2B). In addition, the levels of CCR2 ligands in sera
were clearly correlated with the numbers of infiltrating
CCR2+ inflammatory monocytes (Figure 2C). These re-
sults suggested that robust expression of CCR2 ligands
may contribute to the aggressive recruitment of CCR2+
inflammatory monocytes into the lungs.
Induction of CCR2 ligands by CCR2+ inflammatory
monocytes
We sought to determine whether the infiltrating Gr1 +
CD11b + cells are possible producers of CCR2 ligands.
To test this possibility, total infiltrating leukocytes were
separated into Gr1 + CD11b + cells and Gr1-CD11b- cells
using a cell sorter (Figure 3A). Compared to leukocytes in
the lungs of naïve mice, infiltrating leukocytes harvested
from virus-infected mice had tens- to thousands-fold in-
duction of CCR2 ligands (Figure 3B). The relative fold
induction of CCR2 ligands was similar between total
leukocytes and Gr1 + CD11b + sorted cells, suggesting
that Gr1 + CD11b + cells are probably the main producers
of CCR2 ligands. To confirm that CCR2+ inflammatory
monocytes were producers of CCR2 ligands, granulocytes
and monocytes were sorted from the Gr1 + CD11b +mye-
loid population (Figure 3C). As shown in Figure 3D, both
cell types could express CCL2, CCL7 and CCL12, but
more expression of these CCR2 ligands was seen in mono-
cytes. Thus, our results suggested that infiltrating CCR2+
inflammatory monocytes act positively in a chemokine
feedback loop to recruit more CCR2+ inflammatory
monocytes.
Induction of CCR2 ligands is dependent on IFNAR1-triggered
signaling
We next sought to determine which inflammatory sig-
naling pathway was responsible for the induction of
CCR2 ligands. Previous studies indicated that signaling
pathways of MyD88 and type I IFN could modulate the
recruitment of myeloid cells [19,20]. Therefore, MyD88−/−
and IFNAR1−/− mice were used in this study. Compared
to infected WT and MyD88−/− mice, the expression of
CCR2 ligands by Gr1 + CD11b + cells was significantly
reduced in infected IFNAR1−/− mice (Figure 4A). Inaddition, we found that the percentage of CCR2+ inflam-
matory monocytes was only reduced in IFNAR1−/− mice.
In Figure 4B, CCR2+ inflammatory monocytes accounted
for 81.8 ± 1.1% of total leukocytes in infected WT mice
and 84.5 ± 4.5% in infected MyD88 deficient mice; how-
ever, CCR2+ inflammatory monocytes accounted for
only 39.8 ± 0.35% in infected IFNAR1−/− mice. Thus,
accumulation of CCR2+ inflammatory monocytes was
suppressed when the IFNAR1-induced expression of
CCR2 ligands was interrupted. Because aggressive re-
cruitment of Gr1 + CD11b + cells was observed after
day 3 post-infection (Figure 1E), we wondered whether
intranasal treatment with an anti-IFNAR1 blocking
antibody at day 3 post-infection could interrupt the in-
flux of CCR2+ inflammatory monocytes. In Figure 4C
and D, the recruitment of CCR2+ inflammatory mono-
cytes was reduced significantly in anti-IFNAR1 blocking
antibody-treated mice, but not in isotype control-treated
mice. Overall, these data implied that excessive recruit-
ment of CCR2+ inflammatory monocytes contributes to
continuous activation of IFNAR1-induced expression of
CCR2 ligands.
Impaired anti-viral responses prolong IFNβ expression
Type I IFNs (IFNα and IFNβ) are considerd to bind the
heterodimeric complexes of IFNAR1 and IFNAR2. Recent
study has shown that induction of CCL2 and CCL7 is trig-
gered by the IFNAR1-IFNβ signaling in IFNAR2−/− mice
[21]. In addition, we also observed differential expression
of CCR2 ligands among Gr1 + CD11b + sorted cells in
141, SOIV and PR8 infections (Figure 3B). Therefore, we
examined the expression levels of IFNβ in all infected
mice. As expected, expression of IFNβ as detected only in
the Gr1 + CD11b + sorted cells harvested from PR8-
infected mice at day 7 post-infection (Figure 5A). In add-
tion, both granulocytes and monocytes in Gr1 + CD11b +
population could express IFNβ (data not shown). Because
detectable IFNβ production reflects activated viral replica-
tion, the anti-viral responses of the host were examined by
measuring virus titers and detecting influenza NP expres-
sion in the infected lung. As shown in Figure 5B and C,
141-infected mice completely eliminated the virus at
day 7. SOIV-infected mice still showed weak expression
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Figure 3 CCR2+ inflammatory monocytes produce high amounts of CCR2 ligand. Total leukocytes were harvested from naïve or virus-infected
mice at day 7 post-infection. (A) Gr1 + CD11b + and Gr1-CD11b- cells were sorted form total leukocytes using a cell sorter. (B) RNAs were extracted from
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Figure 4 Induction of CCR2 ligands is dependent on the IFNAR1-triggered signaling. (A) Gr1 + CD11b +myeloid cells were isolated from the
lungs of PR8-infected WT, MyD88−/− and IFNAR1−/− mice and RNAs were extracted. Expression of CCL2, CCL7 and CCL12 was measured by RT-QPCR.
The mRNA relative folds were determined by normalizing the level of each group to its GAPDH and then to WT infected mice (mean ± SEM; ns: no
significant difference; ***P < 0.001). These data are a composite of three independent experiments (n = 6 mice per group). (B) Total leukocytes
were isolated from PR8-infected WT, MyD88−/− or IFNAR1−/− mice and the cells were stained with anti-Gr1, −CD11b, −Ly6C and -CCR2 Abs. The
percentage of Ly6ChighCCR2+ inflammatory monocytes in Gr1 + CD11b + gated cells is shown. This is a representative result of two repeated
experiments with two-three mice per group. (C-D) Day 3 PR8-infected mice were treated either with isotype control antibody or
anti-IFNAR1 blocking antibody. After 3 days, leukocytes were harvested and stained with anti-Gr1, −CD11b, −Ly6C and -CCR2 Abs. The percentage of
Ly6ChighCCR2+ inflammatory monocytes in Gr1 + CD11b + gated cells and numbers of Ly6ChighCCR2+ inflammatory monocytes are shown (mean ± SEM;
***P < 0.001). These data are a composite of two independent experiments (Isotype control, n = 5; anti-IFNAR1 Ab treatment, n = 6).
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http://www.jbiomedsci.com/content/21/1/99of NP at day 7 and the host completely cleared the
virus at day 8 post-infection. Of note, PR8-infected
lungs still showed strong NP expression and viral replica-
tion at day 7–8 post-infection. These data suggested that
the duration of IFNβ production is a function of the rate of
viral clearance. Next, we sought to explore why Gr1 +
CD11b + cells produce abundant IFNβ in PR8-infected
mice in the late phase of infection. We hypothesized that
recruited CCR2+ inflammatory monocytes are infected by
the PR8 virus, resulting in amplified production of IFNβ.
Indeed, expression of influenza NP was detected in CCR2+
inflammatory monocytes in PR8-infected mice (Figure 5D).
Thus, our results suggested that impaired clearance of PR8
virus prolonged expression of IFNβ, which led to infected
CCR2+ inflammatory monocytes amplifying their own re-
cruitment by an IFNAR1-triggered chemokine feedback
loop. To determine whether high viral loads are potent in-
ducers for CCR2+ monocyte infiltration, an anti-viral drug,
Oseltamivir, was used to suppress virus replication in in-
fected mice. In Figure 5E, body weight loss was attenuated
when infected mice received Oseltamivir treatment, dem-
onstrating the efficacy of Oseltamivir. Influx of CCR2+
inflammatory monocytes was dramatically reduced in
Oseltamivir-treated mice, compared to PBS-treated mice
(Figure 5F). Taken together, our results supported the con-
cept that continuous recruitment of CCR2+ inflammatory
monocytes by the IFNAR1-triggered chemokine feedback
loop is attributable to the extended duration of IFNβ
expression in the late phase of infection.
The balance of CCR2+ inflammatory monocytes between
the BM and lungs
We next examined the source of infiltrating CCR2+ in-
flammatory monocytes in the host. In general, CCR2+
inflammatory monocytes are generated from the BM and
migrate rapidly to inflamed sites following pathogen inva-
sion [22]. Therefore, we first checked the proportions of
Gr1 + CD11b + cells and CCR2+ inflammatory monocytes
in the PBMC and BM during infection. As shown in
Figure 6A-D, the proportion of Gr1 + CD11b + cells
and CCR2+ inflammatory monocytes in the PBMC was
positively correlated with disease severity. In contrast,
the proportion of CCR2+ monocytes in the BM wasinversely correlated with the severity of inflammation
(Figure 6E). In Figure 6F, total CCR2+ monocytes were
significantly decreased in the BM of PR8-infected mice,
compared to those in 141- and SOIV-infected mice.
These results implied that CCR2+ monocytes are rap-
idly recruited from the BM to the infected lung and
mobilization of these cells is possibly dependent on the
expression of CCR2 ligands. To demonstrate CCR2-
mediated trafficking of inflammatory monocytes to the
lungs, BM-enriched CCR2+ monocytes were isolated
from naïve mice, labeled with CFSE, and then adoptively
transferred to naïve, 141-, SOIV- or PR8-infected mice.
After 2 days, transferred CCR2+ inflammatory mono-
cytes were traced by the CCR2 + CFSE + signals on the
cells (Figure 6G). In Figure 6H, more transferred CCR2 +
CFSE +monocytes were found in PR8-infected lungs than
in those 141- and SOIV-infected lungs. CCR2−/− mice
were used to confirm that influx of CCR2+ inflammatory
monocytes was dependent on CCR2-triggered chemotaxis.
In Figure 6I, the proportion of Gr1 + CD11b + cells was
significantly decreased in infected CCR2−/− mice, com-
pared to WT mice. In Figure 6J, only few CCR2+ inflam-
matory monocytes were detected in the blood and lungs
of infected CCR2−/− mice, suggesting the importance of
CCR2-driven monocytes localization within the infected
lung.Pathological effects of CCR2+ inflammatory monocytes
upon IAV infection
A previous study showed that monocytes are retained in
the BM when they lack CCR2 expression [23]. To investi-
gate the biological consequences of an excessive accumu-
lation of CCR2+ inflammatory monocytes in the lungs,
CCR2−/− mice were used to examine leukocyte infiltra-
tion, cytokine storm, expression of iNOS and the survival
rate after a lethal dose challenge of PR8 virus. In the ab-
sence of infiltrating CCR2+ inflammatory monocytes, total
leukocytes in the lung and expression of CCL1, sICAM-1,
IFNγ, IL-1ra, IL-16, M-CSF, CCL2, CCL12 and CXCL9 in
BALF were decreased, suggesting that CCR2+ inflamma-
tory monocytes contribute to the expression of these mol-
ecules (Figure 7A and B). Consistent with the results from
Figure 5 Impaired clearance of viral replication sustains IFNβ production. Total leukocytes were harvested from naïve or virus-infected mice
at day 7 post-infection. (A) RNA was extracted from total leukocytes, Gr1 + CD11b + sorted cells and Gr1-CD11b- sorted cells. Expression of IFNβ
was measured by RT-QPCR. The mRNA relative folds were determined by normalizing the level of each group to the corresponding GAPDH level
and then to total leukocytes from naïve mice (mean ± SEM). Experiment (n = 3–6 mice per group) was performed twice and one representative is
shown. (B) Lungs were harvested from virus infected mice at the time points indicated and the virus load was measured by plaque assays (n = 3
mice per group; mean ± SEM). (C) Protein lysates of lungs were harvested from infected mice (n = 3 mice per group) on day 7 and expression of
influenza NP was detected by western blotting; β-actin expression served as the internal control. This is a representative result from three repeated
experiments. (D) Total leukocytes were harvested from PR8-infected mice at day 7 post-infection. Expression of influenza NP in Ly6ChighCCR2+ cells
was detected by flow cytometry. This is a representative result from three repeated experiments. (E) Body weight changes of PBS- and
Oseltamivir-treated mice were monitored at day 0, 3 and 6 post-infection (mean ± SEM). (F) Leukocytes were harvested from PBS- and Oseltamivir-treated
mice at day 6 post-infection. Cells were stained with Abs against Gr1, CD11b, Ly6C and CCR2, and then CCR2+ monocytes were analyzed by
flow cytometry. The numbers of CCR2+ inflammatory monocytes were calculated in each group. These data are a composite of two independent
experiments (n = 4 mice per group, mean ± SEM; *P < 0.05).
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http://www.jbiomedsci.com/content/21/1/99cytokine arrays, expression of CCR2 ligands was also
significantly decreased in the infiltrating leukocytes of
CCR2−/− mice, compared to WT mice (Figure 7C). A
previous report has shown that iNOS is induced in acti-
vated myeloid cells and significantly involved in the de-
velopment of IAV-induced pneumonitis [24]. As shownin Figure 7D, Gr1 + CD11b + cells were the predominant
producers of iNOS. Interestingly, expression of iNOS was
correlated with the severity of inflammation. To demon-
strate further the importance of CCR2+ inflammatory
monocytes-mediated immunopathological effects, ex-
pression of iNOS and the survival rate were compared
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http://www.jbiomedsci.com/content/21/1/99in PR8-infected WT and CCR2−/− mice. Expression of
iNOS transcripts was dramatically reduced in infected
CCR2−/− mice, (Figure 7E). Finally, 38.5% of infected
CCR2−/− mice, but none of the WT mice, survived a
lethal dose challenge of PR8 virus (Figure 7F). Thus,
infiltrating CCR2+ inflammatory monocytes play a piv-
otal role in highly virulent IAV infection-mediated
pathological effects.Discussion
IAV not only infect pulmonary epithelial cells, endothe-
lial cells and resident alveolar macrophages but also in-
filtrating granulocytes, monocytes and dendritic cells
[18,25]. Furthermore, infected leukocytes are the main
contributors to aggressive production of inflammatory
innate immune responses. Before entering the inflamed
lung, these uninfected infiltrates are already primed with
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Figure 8 Roles of CCR2+ inflammatory monocytes in highly pathogenic IAV infection. We achieved varying degrees of weight loss with
mildly, moderately or severely inflamed lungs in mice inoculated with the 141, SOIV or PR8 strains. These H1N1 infection models with variable
efficiencies of viral clearance result in the accumulation of varying numbers of CCR2+ inflammatrory monocytes, which are highly associated with
the generation of a cytokine storm and expression of iNOS. In the early phase of infection, we propose that a small number of infiltratng CCR2+
inflammatory monocytes are infected with IAV and respond to autocrine and/or paracrine IFNβ, which induces the expression of the CCR2 ligands,
CCL2, CCL7 and CCL12. Recruited CCR2+ inflammatory monocytes drive further recruitment of CCR2+ inflammatory monocytes from the BM to
the lung through CCR2-dependent chemotaxis. In the late phase of infection, impaired clearance of PR8 virus leads to spread of infection to
recently arrived CCR2+ inflammatory monocytes and to sustained production of the IFNAR1-IFNβ signaling axis-induced CCR2 ligands, which
cause infiltrating CCR2+ inflammatrory monocytes to amplify their own recruitment continuously through the IFNAR1-dependent chemokine
feedback loop.
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http://www.jbiomedsci.com/content/21/1/99type I IFN, which upregulates the levels of MAD5, RIG-I
and IRF7 [26,27]. In addition, these IFN-stimulated mol-
ecules coupled with viral nucleic acids are responsible
for amplified production of type I IFN [28]. Our findings
revealed that the rate of virus clearance determines the
duration of IFNβ expression in infiltrating Gr1 + CD11b +
cells. Sustained expression of IFNβ was critical for aggres-
sive recruitment of CCR2+ inflammatory monocytes in se-
vere inflammation. When virus replication was suppressed
by Oseltamivir, body weight and influx of CCR2+ inflam-
matory monocytes were significantly reduced. These re-
sults indicated that excessive accumulation of CCR2+
inflammatory monocytes plays a crucial role in the
pathological outcomes of highly pathogenic H1N1 IAV
infections. Recently, we are continuously threatened by
sporadic infections by emerging avian influenza viruses,
including highly pathogenic avian H5N1 and H7N9 vi-
ruses which rapidly develop acute respiratory distress
syndrome, including excessive infiltration of neutro-
phils and monocytes into the lungs, high viral loads
and hypercytokinemia [29,30]. Futhermore, it is worth
to see whether the same phenomenon is observed in
avain flu infections, such as H5N1 and H7N9. If accu-
mulation of CCR2+ inflammatory monocytes is a common
phenomenon in highly pathogenic influenza infection,
CCR2+ inflammatory monocytes will be a good thera-
peutic target in infection.
The mechanism of accumulation of CCR2+ inflamma-
tory monocytes in severe IAV infection remains largely
unclear. Previous reports have shown that small num-
bers of neutrophils are recruited early in infection,
followed by influx of large numbers of monocytes [4].
Based on our result, CCR2 ligands produced by neutro-
phils might play a key role in the early recruitment of
monocytes. In Figure 1F, the ratio of neutrophils and
monocytes was skewed according to degrees of inflam-
mation at day 7 post-infection. This result indicated two
things: (1) Monocyte attractive chemokines were not
only provided by neutrophils but also by other inflam-
matory cells. Using cell sorting, we showed that accumu-
lated CCR2+ inflammatory monocytes are the main
contributors of CCR2 ligands and then amplify theirown recruitment. (2) Infiltrating monocytes might inter-
fere with the further influx of neutrophils in severe inflam-
mation. A previous study has demonstrated that type I
IFN suppresses neutrophil-mediated chemokine attrac-
tion, CXCL1 and CXCL2, leading to impaired recruitment
of neutrophils [31]. Therefore, we suggested that sustained
expression of IFNβ from CCR2 inflammatory monocytes
interrupts the recruitment of neutrophils. Indeed, our
data are consistent with previous reports that a doub-
ling of neutrophil numbers is observed in CCR2−/−
and IFNAR1−/− mice [20,32].
Production of type I IFN is a double edged sword in
terms of viral clearance and virus-mediated pathogenesis.
Previous studies have shown that prolonged induction of
type I IFN was seen in highly virulent IAV infections, lead-
ing to severe consequences: (1) Type I IFN-induced apop-
tosis of alveolar epithelial cells by TRAIL is observed in
severe IAV infections [33]. (2) Type I IFN-induced FasL
expression in the epithelial cells of the lung contributes to
the severity of infection [34]. (3) Type I IFN mediates the
development of post-influenza bacterial infections [31]. In
our study, CCR2+ inflammatory monocytes amplify their
own recruitment by a prolonged IFNAR1-triggered che-
mokine feedback loop.
In our study, induction of CCR2 ligands in CCR2+
inflammatory monocytes was dependent on the IFNAR1-
triggered signaling pathway. However, recruitment of
CCR2+ inflammatory monocytes could not be completely
abolished in IFNAR1−/− mice, suggesting that induc-
tion of CCR2 ligands in other cell types by IFNAR1-
independent pathways may not be excluded. Indeed,
expression of CCL2 is regulated by Sphingosine-1-
phosphate receptor-triggered signaling in pulmonary
endothelial cells or by the MyD88-mediated pathway
in pulmonary epithelial cells [35-37]. In addition, IL-
1R signaling is also involved in CCL2 induction in
undefined cell types during IAV infection [38]. A pre-
vious study has demonstrated that mice deficient in a
single ligand, either CCL2 or CCL7, only can block 40-
50% monocytes egressing from the BM [39]. Thus, it is
not surprising that gene deficiency of CCL2 cannot
protect mice against highly pathogenic virus-mediated
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http://www.jbiomedsci.com/content/21/1/99death [7]. Our results indicated that CCL2, CCL7 and
CCL12 were highly induced during IAV infections.
Therefore, blockage of any single CCR2 ligand is not
sufficient to block recruitment of CCR2+ inflammatory
monocytes.
Recuirted CCR2+ inflammatory monocytes play a crit-
ical role in innate and adaptive immune responses dur-
ing IAV infections. In successful clearance of 141 and
SOIV infecions, CCR2+ inflammatory monocytes expressed
high levels of IFNγR, MHC class I and MHC class II mole-
cules than those molecules on monocytes isolated from
PR8-infected mice (data not shown). Our and previous
studies have demonstrated that monocytes are the mainly
susceptible cell type to IAV infections [40,41]. Therefore,
we suggested that the rate of viral clearance markedly
determines the functional direction of inflitrating CCR2+
inflammatory monocytes toward in either protective or
pathological role. In infections of MCMV and LCMV,
CCR2+ inflammatory monocyte-produced large amount
of iNOS and facilitate the production of nitric oxide
(NO). NO plays a critical role to impair anti-CD8 T cell
responses [14,15]. In our study, CCR2+ inflammatory
monocytes expressed iNOS; and its expression was corre-
lated with rate of viral clearance. Thus, these results im-
plied that excessive accumulation of CCR2+ inflammatoy
monocytes might interfere effective anti-viral CD8 T-cell
responses via excessive NO prodution in highly patho-
genic IAV infections.
In summary, overabundant innate immune responses
produced by monocytes contribute significantly to highly
pathogenic virus-mediated fatal outcomes. Based on our
findings, the proportion of CCR2+ inflammatory mono-
cytes in the blood and concentration of CCR2 ligands in
the serum have potential as translational biomarkers to pre-
dict IAV virulence and pathogenesis in an emerging pan-
demic infection and sporadic infections of avian IAVs. In
addition, inhibition of recruitment of CCR2+ inflammatory
monocytes or depletion of infiltrating CCR2+ inflammatory
monocytes may provide an alternative immunothera-
peutic way to reduce the damaging effects of accumulating
CCR2+ inflammatory monocytes in highly pathogenic
IAV infections.
Conclusion
The excessive accumulation of Gr1 + CD11b + cells is
strongly associated with severe lung pathology in highly
pathogenic 1918 H1N1 and avian H5N1 infections [42].
According to a detailed characterization of Gr1 + CD11b +
cells, we found that CCR2+ inflammatory monocytes are
a prominent cell type and that they contribute to over-
abundant inflammatory immune responses. In this study,
we demonstrated that the accumulation of infiltrating
CCR2+ inflammatory monocytes is determined by the effi-
ciency of host in clearing the virus. Based on our findings,the CCR2+ inflammatory monocytes were one of determi-
nants for pathogenicity of highly pathogenic IAV infection
(Figure 8).
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